Science Explorer Interactive view Map
Company · Mumbai · India

Sun Pharma (India)

Research works
58
▲ 15% vs 2013–17
Citations
401
6.9 per fractional work
Top-10% rate
9.9%
record average 16.5%
Open access
39%
world 28%

Not ranked overall: Sun Pharma (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.54× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.16× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.04× its world share, 0 worksImmunology and Micro…Neuroscience: 0.88× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 19.75× its world share, 1 worksPharmacology, Toxico…Chemistry: 4.51× its world share, 1 worksChemistryComputer Science: 0.37× its world share, 0 worksComputer ScienceEngineering: 0.07× its world share, 0 worksEngineeringMaterials Science: 0.88× its world share, 0 worksMaterials ScienceMathematics: 0.93× its world share, 0 worksMathematicsDentistry: 10.11× its world share, 1 worksDentistryHealth Professions: 1.11× its world share, 0 worksHealth ProfessionsMedicine: 2.89× its world share, 8 worksMedicineNursing: 2.22× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.29× its world share, 0 worksEconomics, Econometr…Psychology: 0.52× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 19.8×. Every wedge is a field page.

Which keywords describe research at Sun Pharma (India)?

By fractional works in all years, weighted toward what it does more of than the world: Pharmacokinetics, Adverse Drug Reactions, Antioxidant, Clinical Trials, Cancer Therapy, Medicinal Chemistry, Metabolic Syndrome and Antioxidant Activity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Pharmacokinetics4▲ 25×7 topics
  2. Adverse Drug Reactions4▲ 102×2 topics
  3. Inflammation4▲ 2.8×23 topics
  4. Antioxidant4▲ 9.3×14 topics
  5. Epidemiology4▲ 1.59×23 topics
  6. Clinical Trials4▲ 9.6×5 topics
  7. Metabolic Syndrome3▲ 5.8×11 topics
  8. Nanoparticles3▲ 3.8×8 topics
  9. Cancer3▲ 3.2×13 topics
  10. Cancer Therapy3▲ 7.4×7 topics
  11. Cardiovascular Disease3▲ 3.9×12 topics
  12. Medicinal Chemistry3▲ 12×4 topics
  13. Antioxidant Activity2▲ 8.0×5 topics
  14. Drug Development2▲ 30×2 topics
  15. Off-Label Drug Use2▲ 111×1 topic
  16. Pediatric Pharmacokinetics2▲ 111×1 topic
  17. Molecular Docking2▲ 25×2 topics
  18. Neuroprotective2▲ 30×6 topics
  19. Drug Target Identification2▲ 48×1 topic
  20. Virtual Screening2▲ 48×1 topic
  21. Biomarkers2▲ 5.3×4 topics
  22. Insulin Resistance2▲ 7.0×5 topics
  23. Drug Delivery2▲ 6.5×4 topics
  24. Cyclodextrins2▲ 128×1 topic
  25. Diabetes2▲ 5.7×6 topics
  26. Drug Development Costs2▲ 113×1 topic
  27. Generic Drugs2▲ 113×1 topic
  28. Glaucoma2▲ 18×3 topics
  29. Nutritional Value2▲ 29×2 topics
  30. Solid Dispersions2▲ 128×1 topic
  31. Type 2 Diabetes2▲ 16×3 topics
  32. Cardiovascular Risk2▲ 7.9×5 topics
  33. Clinical Guidelines2▲ 8.7×4 topics
  34. Method Validation2▲ 35×2 topics
  35. Drug Discovery2▲ 6.4×5 topics
  36. Optic Nerve2▲ 26×2 topics
  37. Pharmacovigilance2▲ 205×1 topic
  38. Signal Detection2▲ 205×1 topic
  39. Biological Activities1▲ 13×2 topics
  40. Immunogenicity1▲ 47×3 topics

Which research topics does Sun Pharma (India) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Computational Drug Discovery Methods and Drug Solubulity and Delivery Systems.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  2. 2 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  4. 4 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  5. 5 Oral microbiology and periodontitis research Periodontics 0 works
  6. 6 Epilepsy research and treatment Psychiatry and Mental health 0 works
  7. 7 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  8. 8 Pharmacology and Obesity Treatment Pharmacology 0 works
  9. 9 Crystallization and Solubility Studies Materials Chemistry 0 works
  10. 10 Diverse Scientific Research Studies General Health Professions 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.8%not open61.2%

World: 28% of research is openly available.

with international co-authors17.1%domestic only82.9%

World: 19% is written across borders.

How has Sun Pharma (India)'s research output changed?

Output in 2018–2022 was 15% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mumbai

All research institutions in Mumbai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.